Healthy Future for US Gene Therapy & Biotech Industry in 2022
Investment in gene therapy is going to be positive in 2022, according to industry insiders. With estimates revealing that one family a day is now being treated with gene therapy there is clear motivation among investors to help extend the reach of gene therapy in the coming 12 months. There is so much potential in gene therapy - for example, AAV-mediated gene therapies open up the option for a one-off administration that could tackle the underlying disease and make permanent...
View full press release